CHENGDU OLYMVAX BIOPHARMACEUTICALS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.27 CNY | -3.84% |
|
-5.21% | -41.33% |
| 16/05 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
| 25/04 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 52Cr | - | - | ||||
| 9.48TCr | ||||||
| 3.76TCr | ||||||
| 3.33TCr | ||||||
| 2.79TCr | ||||||
| 1.59TCr |
